建投能源(000600.SZ):壽陽熱電項目機組投產
格隆匯10月27日丨建投能源(000600.SZ)公佈,公司控股子公司冀建投壽陽熱電有限責任公司(下稱“壽陽熱電”)建設的2×350MW低熱值煤熱電聯產項目2號機組於2023年10月27日一次通過168小時滿負荷試運行,正式投入運營。該項目1號機組已於2023年7月19日投產,至此壽陽熱電項目已全部建成投產。
壽陽熱電項目兩台機組均為350MW超臨界循環流化牀空冷供熱發電機組,同步建設全封閉煤場和高效脱硫、脱硝及除塵設施,建成後點對網向華北電網送電。
截至公吿日,公司控股運營裝機容量達985萬千瓦。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.